Pharma Journalist 7836 posts 0 comments

Samsung Biologics and Kurma Partners announced a strategic partnership for the development and manufacturing of biologics for Kurma Partners' portfolio companies. Under the terms of…
Read More...

INVO Bioscience, Inc., a healthcare services company focused on expanding access to advanced fertility treatment worldwide, and NAYA Biosciences Inc. ("NAYA"), a company dedicated to…
Read More...

Taking place during the 14th World ADC San Diego, the 10th World ADC Awards reunited both newcomers and leaders of the antibody-drug conjugate industry this October 18, 2023.…
Read More...

Monte Rosa Therapeutics, Inc. announced it has entered into a strategic collaboration and licensing agreement with global healthcare leader Roche to discover and develop MGDs against…
Read More...

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that ZILBRYSQ (zilucoplan) has been approved by the U.S. Food and Drug Administration (FDA) for the…
Read More...

SpliceBio, a genetic medicines company harnessing Protein Splicing to develop the next generation of gene therapies, is pleased to announce the signing of an exclusive collaboration and…
Read More...

Gilead Sciences, Inc. and Assembly Biosciences, Inc. announced that the companies have entered into a 12-year partnership to advance the research and development of novel antiviral…
Read More...

Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, and GlobalBio, Inc. (GlobalBio), an antibody engineering company…
Read More...

LegoChem Biosciences Inc. (LCB) and Glycotope GmbH (Glycotope) have entered into an exclusive worldwide licensing agreement to develop an antibody drug conjugate (ADC) by combining…
Read More...

Novo Nordisk A/S and KBP Biosciences PTE., Ltd. announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular…
Read More...